Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Not yet recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 1Dermatologic 1

Conditions

Skin Carcinoma 1Carcinoma, Renal Cell 1Carcinoma, Basal Cell 1

Interventions

pembrolizumab 589Cyclophosphamide 539Magnetic Resonance Spectroscopy 523Radiotherapy 506Specimen Handling 503Nivolumab 407Cisplatin 370Carboplatin 358Biopsy 304Blood Specimen Collection 295Radiosurgery 283Paclitaxel 274Surveys and Questionnaires 268Standard of Care 266Gemcitabine 265fludarabine 261Dexamethasone 258Drug Therapy 256venetoclax 246Bevacizumab 246Oxaliplatin 206Rituximab 195Capecitabine 194Radiation 189Fluorouracil 186Ipilimumab 184durvalumab 180Doxorubicin 175atezolizumab 172Etoposide 171

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Aftercare × 1 year × Clear all
NCT00918775 2026-04-15

Follow-up After Metastasectomy in Patients With Kidney Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
86 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT07032701 2026-04-02

A Disposable Negative Pressure Wound Therapy Device (SNaP) to Promote Wound Healing in the Lower Limbs Following Mohs Micrographic Surgery for Non-melanoma Skin Cancer

Jonsson Comprehensive Cancer Center

Phase NA Not yet recruiting
60 enrolled

Skin Carcinoma

NCT07347392 2026-01-16

DOSCA-2

University of Aarhus

Enrolling by invitation
2,900 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡